期刊
FRONTIERS IN PHARMACOLOGY
卷 13, 期 -, 页码 -出版社
FRONTIERS MEDIA SA
DOI: 10.3389/fphar.2022.886981
关键词
mesoporous; silica; nanoparticles; insulin; pharmaceutical; oral
资金
- Research Management Centre, International Islamic University Malaysia, Gombak, Kuala Lumpur
This article provides a brief review of the history of supramolecular mesoporous silica nanoparticles (MSNs) and highlights the influencing factors affecting their morphology-porosity characteristics. It also presents the applications of MSNs as a next-generation drug delivery system, particularly in controlled release dosage forms via an oral drug delivery system.
Supramolecular mesoporous silica nanoparticles (MSNs) offer distinct properties as opposed to micron-sized silica particles in terms of their crystal structure, morphology-porosity, toxicity, biological effects, and others. MSN biocompatibility has touched the pharmaceutical realm to exploit its robust synthesis pathway for delivery of various therapeutic molecules including macromolecules and small-molecule drugs. This article provides a brief review of MSN history followed by special emphasis on the influencing factors affecting morphology-porosity characteristics. Its applications as the next-generation drug delivery system (NGDDS) particularly in a controlled release dosage form via an oral drug delivery system are also presented and shall be highlighted as oral delivery is the most convenient route of drug administration with the economical cost of development through to scale-up for clinical trials and market launch.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据